Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Good momentum in commercial CDMO business
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Subscribe To Our Newsletter & Stay Updated
